Dr. Selma Supek obtained her degrees in physics. She entered the field of functional brain imaging using MEG during her doctoral research in the Biophysics Group, Los Alamos National Laboratory - LANL (1988-1993). After returning to Zagreb, Croatia, she continued collaborations with MEG/EEG laboratories at LANL and Mind Research Network and established new ones at ITAB in Chieti, HUCH BioMag Laboratory, Aalto University, University of Heidelberg, TU Ilmenau, and University of Jena. Research interests of Selma Supek include retinotopic organization of the visual cortex, spatiotemporal resolution of MEG, face processing, cognitive neurodynamics, auditory processing, and translational and educational neuroscience. She introduced functional brain imaging methods, in particular MEG, in Croatia both in research and education programs at diploma and doctoral levels. Selma Supek founded a series of intensive international graduate courses MIND AND BRAIN (www.brain.com.hr) within the academic program of the Inter-University Centre Dubrovnik, and cofounded and codirected the first interdisciplinary international postgraduate program "Language Communication and Cognitive Neuroscience" of the University of Zagreb. She organized and chaired Biomag 2010 (www.biomag2010.org) and serves as a permanent member of the International Advisory Board for Biomag conferences which she chaired in 2010-2012.

Dr. Cheryl Aine has more than 30 years of research experience in the neuroimaging field (e.g., ERPs, MEG, fMRI, DTI, PET, Xenon-133 for imaging rCBF). She is most noted for her work using MEG and has served in several leadership positions (e.g., Deputy Group Leader in the Physics Division at Los Alamos National Laboratory and Director of the MEG groups at the Veterans Affairs, the MIND Institute (currently the Mind Research Network), and the University of New Mexico Department of Radiology in Albuquerque, New Mexico). Her research interests have ranged from basic vision (e.g., retinotopic organization of human visual cortex and visual selective attention), use of simulated data to validate analysis methods, and studies of cognitive decline in clinical populations (e.g., normal aging, mild cognitive impairment/Alzheimer's disease, schizophrenia).